XML 41 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended 138 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Cash flows from operating activities:      
Net income/(loss) for the period $ (48,421) $ (41,728) $ (148,805)
Adjustments to reconcile net income/(loss) for the period to net cash used in operations:      
Depreciation and amortization 542 258 2,940
Stock-based compensation 744 1,992 12,795
Gain on disposal of marketable securities 18 (143) (8,031)
Loss on extinguishment of convertible notes     1,218
Accrued interest and accretion of interest     3,519
Gain on disposal of mineral property   (934) (80,035)
Write-down of non-current assets     7,367
Transaction Costs     1,841
Unrealized (gain)/loss on other investments 47,322 42,316 60,338
Write down of marketable securities     959
Deferred tax (benefit)/expense (15,374) (16,201) 1
Other non-cash items (264)   1,931
Change in working capital account items:      
Other current assets 1,142 (538) (1,072)
Accrued interest payable     (7,586)
Accounts payable, accrued liabilities and other (2,204) (227) 2,592
Net cash used in operating activities (16,495) (15,205) (150,028)
Cash flows from investing activities:      
Purchases of marketable securities   (135) (1,841)
Proceeds from sales of marketable securities 112 230 11,655
Acquisition of long-term investments   (45) (3,632)
Additions to mineral property     (11,571)
Additions to plant and equipment (2,206) (589) (24,849)
Change in restricted cash (30) 41 (100)
Proceeds from additional option agreement   3,500 6,740
Cash transferred to Allied Nevada Gold Corp., net of receivable     (24,517)
Net cash (used in)/provided by investing activities (2,124) 3,002 (48,115)
Cash flows from financing activities:      
Net proceeds from equity financings     161,542
Proceeds from debt financing (Note 8) 9,637   9,637
Repayment of convertible notes     (26,108)
Proceeds from exercise of warrants   1,100 40,754
Proceeds from exercise of compensation options   733 733
Proceeds from exercise of stock options     4,068
Issuance of convertible notes     28,345
Cash paid in lieu of capital stock issuances     (107)
Transaction costs     (1,841)
Net cash provided by financing activities 9,637 1,833 217,023
Increase/(decrease) in cash and cash equivalents (8,982) (10,370) 18,880
Decrease in cash and cash equivalents - discontinued operations     (10,255)
Net increase/(decrease) in cash and cash equivalents (8,982) (10,370) 8,625
Cash and cash equivalents, beginning of period 18,281 17,873 674
Cash and cash equivalents, end of period $ 9,299 $ 7,503 $ 9,299